相关实验视频

Updated: May 4, 2026

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

在帕金森病中,双重作用的策略是为α-synuclein聚合物的清除重编程伴侣活性

Oliwia Koszła¹, Przemysław Sołek², Joanna Depciuch³

¹Department of Biopharmacy, Medical University of Lublin, 20-093, Lublin, Poland.

International journal of biological macromolecules

|February 6, 2026

概括

复星和化的结合显示出对帕金森病的治疗有前途. 这种联合疗法有效清除有毒的α-synuclein聚合物,并激活细胞修复机制,提供了一种新的治疗途径.

科学领域:

神经科学是一个神经科学.
分子生物学分子生物学
药理学药理学是指药理学的学科.

背景情况:

帕金森病 (PD) 是一种神经退行性疾病,与有毒的α-synuclein (α-syn) 聚合有关.
分子陪伴者对于蛋白质平衡和清除错误折叠的蛋白质至关重要.
现有的PD治疗方法在治疗α-syn病理方面存在局限性.

研究的目的:

在体外帕金森病模型中研究复星和化的联合治疗潜力.
评估这种联合治疗对α-synuclein水平,聚合和细胞健康的影响.
评估组合疗法激活分子陪伴系统的情况.

主要方法:

使用的人类LUHMES细胞受到预先形成的α-synuclein纤维素 (PFF) 的挑战.
单疗法和联合治疗对α-synuclein,细胞活力,新陈代谢,氧化应激,侵略体和伴侣激活的评估影响.
采用富里埃变换红外光谱仪 (FTIR) 来进行生物化学分析.

主要成果:

同时治疗显著降低了非酸化和酸化α-synuclein水平和侵略性形成.
联合的白醇和化强烈地激活了细胞分子陪伴者系统.
联合治疗保留了细胞活力和代谢活动,而不会增加氧化应激.
FTIR分析表明恢复正常细胞分子特征的趋势.

结论:

复星和化在清除神经毒性α-synuclein聚合物的过程中表现出协同作用.
联合疗法通过伴侣激活来增强蛋白质质量控制,提供神经保护.
这种组合代表了帕金森病的有希望的补充治疗策略.

关键词:

纤维丝是纤维丝的组成部分.化的化是一种化.错误折叠的蛋白质是什么分子的伴侣是分子的伴侣.蛋白质质量控制蛋白质质量控制复星醇是一种复星.α-Synuclein 是一种蛋白质.

更多相关视频

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Recombinant α- β- and γ-Synucleins Stimulate Protein Phosphatase 2A Catalytic Subunit Activity in Cell Free Assays

Published on: August 13, 2017

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

A Method to Study α-Synuclein Toxicity and Aggregation Using a Humanized Yeast Model

Published on: November 25, 2022

相关概念视频

Neural Regulation

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.

Amyloid Fibrils

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...

Alzheimer's Disease: Treatment

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...